Profile for Mexico Patent: 339209
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Mexico Patent: 339209
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jun 6, 2031 | Indivior | SUBLOCADE | buprenorphine |
| ⤷ Start Trial | Jun 25, 2031 | Indivior | SUBLOCADE | buprenorphine |
| ⤷ Start Trial | Jun 6, 2031 | Indivior | SUBLOCADE | buprenorphine |
| ⤷ Start Trial | Jan 6, 2032 | Indivior | SUBLOCADE | buprenorphine |
| ⤷ Start Trial | Sep 5, 2031 | Indivior | SUBLOCADE | buprenorphine |
| ⤷ Start Trial | Jun 6, 2031 | Indivior | SUBLOCADE | buprenorphine |
| ⤷ Start Trial | Jun 6, 2031 | Indivior | SUBLOCADE | buprenorphine |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
